Since 1972, Doctor's Data, Inc. (DDI) has been providing innovative specialty testing to healthcare practitioners worldwide from their advanced clinical laboratory. As specialists and pioneers in essential and toxic elemental testing, they offer a wide range of functional tests to support decision-making and enhance patient outcomes. Their mission is to research, develop, and offer innovative tests that help healthcare practitioners identify health risks and improve outcomes for patients with chronic conditions. They also focus on educating and supporting healthcare professionals, aiming to improve lives through science. DDI assists in assessing and treating heavy metal burden, nutritional deficiencies, gastrointestinal function, hormone status, cardiovascular risk, liver and metabolic abnormalities, and more.

Research Commitment

DDI supports cutting-edge research in collaboration with prominent global institutions. Their research focuses on raising awareness of the role of elements in clinical biochemistry and medicine. They have participated in studies on:

• Intellectual and neurological development and behaviour in children
• The adverse effects of toxic waste and heavy industrialisation on hypertension, cardiovascular disease and other conditions
• The biochemical connection between aberrant behaviour and violence in juveniles and adults
• Zinc deficiency and suppression of growth in humans

They have partnered with Argonne National Laboratory, Brookhaven National Laboratory, Johns Hopkins Hospital, the European Commission Joint Research Centre, the United States Navy, the California Criminal Justice System, the Oklahoma Department of Health and Human Services, and the universities of California, Florida, Illinois, and Texas, among others.

Clinical Laboratory and Technologies

Doctor's Data has created a modern facility equipped with the most advanced instrumentation to support their scientific team. The laboratory is designed to ensure optimal cleanliness, contamination control and streamlined specimen flow. The team uses advanced instruments such as dynamic reaction cell inductively coupled plasma mass spectrometry (DRC-ICP/MS) for elemental analysis, DNA amplification assays, and automated identification and antimicrobial sensitivity instruments for detecting bacterial resistance mechanisms and phenotypes in their clinical microbiology department.

Pioneering Technologies

Committed to accurate, sensitive, and cost-effective analysis, DDI employs the best available techniques. They were among the first clinical reference laboratories to use ICP-MS and high-resolution ICP-MS and are leaders in GC/MS, UHPLC, LC/MS QQQ, and the latest automated microbiology systems.

• College of American Pathologists (CAP)
• Clinical Laboratory Improvement Amendments (CLIA)
• Centers for Disease Control (CDC)
• Le Centre de Toxicologie du Quebec
• American Proficiency Institute Certificate
• DEQAS Vitamin D Certificate
• EQUIP Certificate
• European Commission Joint Research Center Validated Supplier for Trace Elements
• New York State Department of Health
• Maryland Department of Health Laboratory Permit
• Ohio Department of Health Laboratory Approval
• Pennsylvania Department of Health Clinical Laboratory Permit
• State of California Clinical Laboratory License
• State of Rhode Island and Providence Plantations - Department of Health

Quality Control Measures

DDI prioritises consistent and accurate results through highly trained personnel, advanced instrumentation, continuous client education, robust data management, and comprehensive quality assurance.Their quality programme rigorously monitors precision, accuracy, and detection limits, with samples also sent to other laboratories for comparison. The programme addresses key service aspects such as result turnaround time, analysis cost, results interpretation, and customer service, ensuring timely and reliable outcomes.Participation in proficiency testing programmes, including those by the College of American Pathologists, and ongoing quality control sample analysis guarantee that DDI's results meet clinical needs. Additionally, their involvement in scientific research enhances their understanding of clinical data, benefiting healthcare practitioners.